Frühe vs. spätere Therapie mit Abirateron plus Prednison bei chemotherapie-naiven, asymptomatischen bis mild symptomatischen Patienten mit metastasiertem CRPC nach Androgendeprivation

Translated title of the contribution: Early- vslate-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy

Axel S. Merseburger, Christoph Rüssel, Hanjo Belz, Philipp Spiegelhalder, Susan Feyerabend, Nguyen Tran, Katrin Kruetzfeldt*, Werner Baurecht, Martin Bögemann

*Corresponding author for this work
1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Early- vslate-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Neuroscience

Immunology and Microbiology